Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:application |
gptkb:disease
immunology neurology oncology |
| gptkbp:awards |
gptkb:Fierce_Innovation_Award_(2019)
|
| gptkbp:CEO |
gptkb:Masoud_Toloue
|
| gptkbp:collaboratesWith |
gptkb:NHLBI
gptkb:Bill_&_Melinda_Gates_Foundation |
| gptkbp:focus |
digital immunoassay
ultrasensitive biomarker detection |
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
gptkb:David_Walt
|
| gptkbp:headquartersLocation |
gptkb:Billerica,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Quanterix
|
| gptkbp:industry |
gptkb:biotechnology
life sciences |
| gptkbp:numberOfEmployees |
400+
|
| gptkbp:product |
gptkb:HD-X_Analyzer
gptkb:SR-X_Analyzer gptkb:Simoa_technology |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:QTRX
|
| gptkbp:technology |
gptkb:Single_Molecule_Array_(Simoa)
|
| gptkbp:website |
https://www.quanterix.com/
|
| gptkbp:bfsParent |
gptkb:David_Walt
|
| gptkbp:bfsLayer |
5
|